CYP19A1 and polycystic ovary syndrome: The reduction of testosterone in rats with PCOS after treatment with genistein was possibly caused by the inhibition of aromatase activity (conversion of androgen hormones into estrogens) induced by estradiol components (Weber et al., 2001; Rajan et al., 2017).